Newspaper November 25 (Reporter Pang Chao) Today, Sino-German joint development of medical devices in high-tech zones in Shijiazhuang laboratory inaugurated. In Shijiazhuang City, the German state of Brandenburg on the basis of cooperation, the two sides will set up business and technology center in Shijiazhuang City, the high-end platform for cancer diagnosis and treatment of international advanced technology and build global research and development centers, production and sales base.

This project, funded by the German Lutong Hebei Biotechnology Co., Ltd. invested. Two years ago, the company began to detect tumor cells has advanced technology company in Germany GILUPI injection, to now become the largest shareholder, the German company to gain more than 30 new technologies, holds the patent rights to explore a Hebei enterprises to go the way of technology and the introduction of new products. The first phase project has invested 50 million yuan, the construction of 3300 square meters of cancer treatment technology research and development laboratories and 100,000 sets of circulating tumor cells detector test base. 2015 -2018, the project two will invest 1.1 billion yuan to expand production capacity, with an annual output of circulating tumor cells in the detector 2.5 million sets of production capacity, is expected to achieve annual output value of 2.5 billion yuan.

。